Literature DB >> 35016490

The current status, attitudes, and practices concerning maternal pertussis vaccination in obstetric delivery facilities in Kanagawa Prefecture, Japan: a questionnaire survey.

Kazuya Hiiragi1, Soichiro Obata1, Etsuko Miyagi2, Shigeru Aoki1.   

Abstract

This study investigated the implementation status, attitudes, and practices regarding maternal pertussis vaccination in delivery facilities in Kanagawa, Japan. We conducted a questionnaire survey of pertussis vaccination during pregnancy at 125 delivery service facilities, excluding midwifery clinics, in Kanagawa Prefecture from June 18 to July 20, 2020. The questionnaire comprised multiple-choice items, with single or multiple answers depending on the question. Of the 125 facilities surveyed, valid responses were obtained from 72 facilities (58%). There were 41 primary clinics with birthing facilities (57%), 16 general hospitals (not designated perinatal centers) (22%), 10 regional perinatal centers (14%), and five tertiary perinatal centers (7%). None of the facilities administered pertussis vaccination during pregnancy. Forty facilities (56%) reported knowledge of the severity of neonatal and infant pertussis infections. Twenty-three facilities (32%) reported knowledge of the prevention of pertussis infection by vaccination during pregnancy. All facilities reported willingness to consider vaccination if included in the Japanese guidelines. In Japan, the pertussis vaccination during pregnancy is not highly practiced by obstetricians; thus, it is not as popular as in other countries. Further studies are needed to promote strategies to prevent pertussis infection in the neonatal and infant periods.

Entities:  

Keywords:  Neonatology; infections-non obstetrics; medical education; pediatrics; pertussis vaccination

Mesh:

Year:  2021        PMID: 35016490      PMCID: PMC8828058          DOI: 10.1080/21645515.2021.1958609

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  8 in total

1.  Pertussis vaccines: WHO position paper - September 2015.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2015-08-28

2.  Questionnaire survey on maternal pertussis vaccination for pregnant women and mothers in Nara prefecture, Japan.

Authors:  Taito Kitano; Tomoko Onishi; Masahiro Takeyama; Midori Shima
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

3.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

4.  Effectiveness of maternal pertussis vaccination in England: an observational study.

Authors:  Gayatri Amirthalingam; Nick Andrews; Helen Campbell; Sonia Ribeiro; Edna Kara; Katherine Donegan; Norman K Fry; Elizabeth Miller; Mary Ramsay
Journal:  Lancet       Date:  2014-07-15       Impact factor: 79.321

5.  The Epidemiology of Nationally Reported Pertussis in the United States, 2000-2016.

Authors:  Tami H Skoff; Stephen Hadler; Susan Hariri
Journal:  Clin Infect Dis       Date:  2019-05-02       Impact factor: 9.079

6.  Safety of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccine in Adults in Japan.

Authors:  Mugen Ujiie; Shinya Tsuzuki; Michiyo Suzuki; Masayuki Ota; Tetsuya Suzuki; Hidetoshi Nomoto; Kei Yamamoto; Sho Saito; Akatsuki Kokaze; Noriko Kinoshita
Journal:  Jpn J Infect Dis       Date:  2021-01-29       Impact factor: 1.362

7.  Incidence and Burden of Pertussis Among Infants Less Than 1 Year of Age.

Authors:  Cristina Masseria; Carolyn K Martin; Girishanthy Krishnarajah; Laura K Becker; Ami Buikema; Tina Q Tan
Journal:  Pediatr Infect Dis J       Date:  2017-03       Impact factor: 2.129

8.  Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study.

Authors:  Tony Walls; Patricia Graham; Helen Petousis-Harris; Linda Hill; Nicola Austin
Journal:  BMJ Open       Date:  2016-01-06       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.